Y
Yun-Qing Qiu
Researcher at Zhejiang University
Publications - 9
Citations - 1991
Yun-Qing Qiu is an academic researcher from Zhejiang University. The author has contributed to research in topics: Proto-oncogene tyrosine-protein kinase Src & Interquartile range. The author has an hindex of 7, co-authored 9 publications receiving 1649 citations.
Papers
More filters
Journal ArticleDOI
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
Xiao-Wei physician Xu,Xiao-Xin physician Wu,Xian-Gao physician Jiang,Kai-Jin physician Xu,Ling-Jun physician Ying,Chun-Lian physician Ma,Shi-Bo physician Li,Hua-Ying physician Wang,Sheng physician Zhang,Hai-Nv Gao,Jifang Sheng,Hong-Liu physician Cai,Yun-Qing Qiu,Lanjuan Li +13 more
TL;DR: As of early February 2020, compared with patients initially infected with SARS-Cov-2 in Wuhan, the symptoms of patients in Zhejiang province are relatively mild.
Journal ArticleDOI
Screening and Identification of Six Serum microRNAs as Novel Potential Combination Biomarkers for Pulmonary Tuberculosis Diagnosis
Xing Zhang,Jing Guo,Shufeng Fan,Yanyuan Li,Li-Liang Wei,Xiuyun Yang,Tingting Jiang,Zhong-Liang Chen,Chong Wang,Jiyan Liu,Ze-Peng Ping,Dandan Xu,Jiaxiong Wang,Zhong-Jie Li,Yun-Qing Qiu,Ji-Cheng Li +15 more
TL;DR: This study suggests that a combination of six serum miRNAs have great potential to serve as non-invasive biomarkers of pulmonary TB.
Journal ArticleDOI
Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ‐coupled two‐dimensional LC‐MS/MS
Dandan Xu,Dan-Feng Deng,Xiang Li,Li-Liang Wei,Yanyuan Li,Xiuyun Yang,Wei Yu,Chong Wang,Tingting Jiang,Zhong-Jie Li,Zhong-Liang Chen,Xing Zhang,Jiyan Liu,Ze-Peng Ping,Yun-Qing Qiu,Ji-Cheng Li +15 more
TL;DR: A panel of serum biomarkers including APOCII, CD5L, HABP2, and RBP4 was obtained to form the disease diagnostic model and revealed that the differentially expressed proteins were related to the response to stimulus, the metabolic and immune system processes.
Journal ArticleDOI
Open-label phase I clinical trial of Ad5-EBOV in Africans in China.
Lihua Wu,Zhe Zhang,Hainv Gao,Yu-Hua Li,Li-Hua Hou,Hangping Yao,Shipo Wu,Jian Liu,Ling Wang,You Zhai,Huilin Ou,Meihua Lin,Xiaoxin Wu,Jingjing Liu,Guanjing Lang,Qian Xin,Guolan Wu,Li Luo,Pei Liu,Jianzhong Shentu,Nanping Wu,Jifang Sheng,Yun-Qing Qiu,Wei Chen,Lanjuan Li +24 more
TL;DR: The application of Ad5-EBOV demonstrated safe in Africans in China and a specific GP antibody and T-cell response could occur 14 d after the first immunization, which provides a reliable basis to proceed with trials in Africa.
Journal ArticleDOI
Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: A retrospective study.
TL;DR: This research presents a novel probabilistic procedure called “spot-spot analysis” that allows for real-time analysis of the response of the immune system to foreign substance abuse.